Radio Compass Blog | Pharmaceutical Articles at Pharmacompass.com

22 Jun 2017

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

A review of the Drug Master Files (DMFs) submitted to the United States Food and Drug Administration (FDA) from October 2016 to March 2017 (the fourth quarter of 2016 and the first quarter of 2017) indicates an extremely robust ph...

Radio Compass

PharmaCompass.com

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

22 Jun 2017

Investors up ante against Mylan board; More Ipca products banned from the US

This week, Phispers looks at fresh troubles brewing at Mylan, as rebel investors intensify their demand for remaking the board, and a low-cost rival for EpiPen gets FDA nod. Meanwhile, BMS sold off its API plant in Ireland to Sout...

Radio Compass

PharmaCompass.com

Investors up ante against Mylan board; More Ipca products banned from the US

15 Jun 2017

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk while increasing the risk of amputation of toes. There is news from Google, which is tying up with India’s Aravind Eye...

Radio Compass

PharmaCompass.com

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

Top BLOG & ANALYSIS

Product Sales Data From Annual Reports of Major Pharmaceutical Companies // 2016

19 Apr 2017
Drugs with No Patents and No Competition - May 2017 FDA Orange Book Review

01 Jun 2017
Active Pharmaceutical Ingredient Drug Master Files (DMFs) Submitted to the U.S. FDA in Q4 2016 & Q1 2017

22 Jun 2017
Top drugs by sales in 2016: Who sold the blockbuster drugs?

19 Apr 2017
Divi’s inspection reveals FDA’s shifting focus beyond audit trails

29 Mar 2017
FDA cites data-integrity concerns at Mylan, product quality issues at Indoco

13 Apr 2017
Chemical entities SHINE in the top 10 fastest-growing drugs of 2016

17 May 2017
Warning letters reveal issues at Divi’s India, Teva China and Lonza USA

27 Apr 2017
ICH Q11: The regulation that will transform the global pharma supply chain

04 May 2017
Market challenges end India’s pharma honeymoon

01 Jun 2017
Teva may get foreign CEO; FDA warns drug makers to check water systems

25 May 2017
PharmaCompass finds 500 drugs with ‘no patents and no competition’ in the FDA Orange Book

01 Jun 2017
"FDA’s enforcement actions are putting the global pharmaceutical supply chain at risk"

06 Apr 2017
Big changes at Teva; FDA approves one of the world’s costliest drugs

04 May 2017
Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!

11 May 2017
WHO grants all clear to Mylan’s India facility, where FDA had data-integrity concerns

08 Jun 2017
Trumpcare receives a blow; EMA to suspend 300 drugs due to clinical data integrity violations in India

30 Mar 2017
J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

15 Jun 2017
Could the Ranbaxy whistleblower head the FDA office in India?; Reprieve for GSK as Mylan’s Advair generic gets delayed

06 Apr 2017
Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs

13 Apr 2017
Sanofi lawsuit highlights Mylan’s unfair trade practices; Fresenius goes on multi-billion dollar spending spree

27 Apr 2017
More bad news engulfs Teva; India to bring laws so that doctors prescribe generics

20 Apr 2017
FDA reorganizes inspection staff; Thermo Fisher buys Patheon for $ 5.2 billion

18 May 2017
After beef, India may ban gelatin capsules; GSK, Gilead’s HIV race heats up

08 Jun 2017
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

22 Jun 2017
Lesser known Indian firms show blatant disregard for compliance, get FDA warning letters

11 May 2017
Investors up ante against Mylan board; More Ipca products banned from the US

22 Jun 2017